newest glp 1 agonist Glucagon-like peptide receptor agonists (GLP-1 RAs): summary of GLP-1 Drug Savings: A Complete
Description
GLP-1 drugs have made significant scientific and market gains, but their most important effects are on people's lives

12,19-24 Weight loss was due to reductions in fat mass rather than lean tissue mass
68,69 Adverse effects of GLP-1RA include gastrointestinal side effects (nausea, vomiting, diarrhea), increased heart rate, and injection site reactions

In EMPA-KIDNEY, a prespecified subgroup analysis showed smaller relative risk reductions among participants with lower baseline albuminuria, likely due to a lower event rate [48]

Nausea may diminish over the course of therapy and can be managed by gradually increasing the dose [119, 120]

March 5, 2025
